Rethinking Cancer Naming: The Case for Genetic-Based Classification
Fabrice André, a medical oncologist, advocates for a new cancer naming system that focuses on the molecular characteristics of tumors rather than their tissue of origin, as genetic alterations can drive cancer growth and treatment responses. This approach could lead to faster access to targeted therapies and benefit patients with rare cancers, as well as improve patient understanding and engagement with their treatment.